AFP and cancer: Biomarkers of cancer risk, such as alpha-fetoprotein (AFP), carbohydrate antigen 19–9 (CA 19-9), carcinoembryonic antigen (CEA), and prostate-specific antigen (PSA), are crucial in evaluating the potential health impacts of these products.